Affiliated Managers Group, Inc. has completed its investment in Forbion Group Holding B.V., a leading life sciences venture capital firm with €3 billion in assets under management.

Target Company Overview

Forbion Group Holding B.V. (“Forbion”) is a distinguished pan-European venture capital and growth equity firm that concentrates on investing in high-quality life sciences companies across various development stages. With approximately €3 billion in assets under management, Forbion is dedicated to providing both capital and expertise to empower life sciences companies in creating innovative therapeutics that can significantly influence the future of healthcare. The firm, co-founded by experienced Managing Partners Sander Slootweg, Geert-Jan Mulder, and Martien van Osch, boasts a seasoned team that has achieved impressive returns for its clients over two decades, continuing to spearhead the advancement of breakthrough drug therapies into the global market.

Industry Overview

The life sciences industry in Europe plays a pivotal role in advancing healthcare solutions, particularly through biotechnology and pharmaceuticals. The sector has witnessed considerable growth driven by increased investments in research and development, with a growing focus on precision medicine and personalized therapies. The European Union actively supports life sciences initiatives, recognizing their impact on public health and economic development.

Moreover, the rise of innovative start-ups within the life sciences landscape has cultivated a dynamic ecosystem conducive to collaboration between academia, industry,